AstraZeneca (AZN)
NASDAQ: AZN
· Real-Time Price · USD
78.79
0.32 (0.41%)
At close: Aug 15, 2025, 12:14 PM
AstraZeneca Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 30, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 14.46B | 13.59B | 14.89B | 13.56B | 12.94B | 12.68B | 12.02B | 11.49B | 11.42B | 10.88B | 11.21B | 10.98B | 10.77B | 11.39B | 12.01B | 9.87B | 8.22B | 7.32B |
Cost of Revenue | 2.47B | 2.23B | 2.73B | 3.08B | 2.18B | 2.22B | 2.31B | 2.1B | 1.96B | 1.91B | 2.9B | 2.98B | 3B | 3.51B | 4.63B | 3.76B | 2.19B | 1.86B |
Gross Profit | 11.98B | 11.36B | 12.17B | 10.48B | 10.76B | 10.46B | 9.72B | 9.4B | 9.46B | 8.97B | 8.31B | 8B | 7.77B | 7.88B | 7.39B | 6.11B | 6.03B | 5.46B |
Operating Income | 3.51B | 3.67B | 2.04B | 2.11B | 2.75B | 3.12B | 1.23B | 1.95B | 2.46B | 2.55B | -342M | 1.25B | 539M | 878M | -292M | -1.67B | 1.13B | 1.9B |
Interest Income | 68M | 84M | 64M | 183M | 100M | 111M | 65M | 101M | 64M | 78M | 31M | 15M | 18M | 17M | 1M | 15M | 7M | 20M |
Pretax Income | 3.13B | 3.4B | 1.67B | 1.83B | 2.4B | 2.8B | 897M | 1.65B | 2.09B | 2.26B | 778M | 922M | 247M | 553M | -636M | -2B | 764M | 1.61B |
Net Income | 2.45B | 2.92B | 1.5B | 1.43B | 1.93B | 2.18B | 960M | 1.37B | 1.82B | 1.8B | 901M | 1.64B | 360M | 386M | -347M | -1.65B | 550M | 1.56B |
Selling & General & Admin | 5.01B | 4.57B | 5.55B | 5.29B | 5.06B | 4.63B | 3.98B | 4.93B | 5.12B | 4.19B | 4.78B | 4.4B | 4.81B | 4.96B | 5.24B | 2.99B | 3.2B | 3.03B |
Research & Development | 3.55B | 3.16B | 4.68B | 3.12B | 3.01B | 2.78B | 3.07B | 2.58B | 2.67B | 2.61B | 2.63B | 2.36B | 2.55B | 2.13B | 2.58B | 2.15B | 1.83B | 1.71B |
Other Expenses | -79M | -52M | -100M | -25M | -60M | n/a | n/a | n/a | n/a | -138M | -189M | 949M | -122M | -97M | -2.43B | 2.3B | -128M | -1.18B |
Operating Expenses | 8.48B | 7.68B | 10.13B | 8.38B | 8.01B | 7.35B | 7.71B | 7.44B | 7B | 6.67B | 7.21B | 6.59B | 7.23B | 7B | 7.68B | 7.44B | 4.9B | 3.56B |
Interest Expense | 439M | 349M | 429M | 457M | 443M | 413M | 408M | 392M | 431M | 365M | 344M | 339M | 311M | 336M | 312M | 335M | 326M | 303M |
Selling & Marketing Expenses | 143M | 132M | 143M | 145M | 132M | 135M | 17.83B | 129M | 131M | 134M | 4.78B | 126M | 4.81B | 4.96B | 5.24B | 2.99B | 3.2B | 3.03B |
Cost & Expenses | 10.95B | 9.91B | 12.86B | 11.46B | 10.19B | 9.56B | 10.02B | 9.54B | 8.96B | 8.57B | 10.11B | 9.57B | 10.23B | 10.51B | 12.3B | 11.2B | 7.09B | 5.42B |
Income Tax Expense | 679M | 481M | 166M | 395M | 469M | 620M | -62M | 274M | 268M | 458M | -124M | -720M | -113M | 165M | -290M | -350M | 214M | 46M |
Shares Outstanding (Basic) | 3.1B | 3.1B | 3.1B | 3.11B | 3.11B | 3.1B | 3.1B | 3.1B | 3.1B | 3.1B | 3.1B | 3.1B | 3.1B | 3.1B | 3.09B | 2.99B | 2.62B | 2.62B |
Shares Outstanding (Diluted) | 3.12B | 3.12B | 3.12B | 3.12B | 3.12B | 3.12B | 3.12B | 3.12B | 3.12B | 3.12B | 3.12B | 3.12B | 3.12B | 3.12B | 3.09B | 2.99B | 2.64B | 2.64B |
EPS (Basic) | 0.79 | 0.94 | 0.49 | 0.46 | 0.62 | 0.71 | 0.31 | 0.45 | 0.59 | 0.58 | 0.29 | 0.53 | 0.12 | 0.13 | -0.11 | -0.55 | 0.21 | 0.60 |
EPS (Diluted) | 0.79 | 0.94 | 0.48 | 0.46 | 0.62 | 0.70 | 0.31 | 0.44 | 0.59 | 0.58 | 0.29 | 0.53 | 0.12 | 0.13 | -0.11 | -0.55 | 0.21 | 0.59 |
EBITDA | 4.96B | 5.08B | 4.43B | 4.1B | 4.12B | 4.57B | 2.18B | 3.33B | 3.68B | 3.89B | 2.38B | 2.56B | 1.96B | 2.2B | 1.87B | 1.12B | 1.88B | 2.71B |
EBIT | 3.57B | 3.8B | 2.1B | 2.29B | 2.84B | 3.21B | 1.3B | 2.04B | 2.46B | 2.63B | 1.12B | 1.25B | 539M | 889M | -324M | -1.67B | 1.09B | 1.91B |
Depreciation & Amortization | 1.39B | 1.28B | 2.34B | 1.82B | 1.28B | 1.25B | 874M | 1.28B | 1.28B | 1.5B | 1.25B | 1.33B | 1.36B | 1.31B | 2.19B | 2.79B | 753M | 797M |